Esmolol for better oxygen in ARDS patients
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests if esmolol, a heart-slowing drug, can improve oxygen levels in patients with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It may help by adjusting heart rate to a specific range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute respiratory distress syndrome (ARDS) as defined by standard criteria.
- You are between 18 and 65 years old.
- Your resting heart rate is between 95 and 120 beats per minute.
- You need a breathing tube and a mechanical ventilator.
- You (or your legal representative) can sign a consent form.
- You do not have certain heart conditions, like a slow heart rate or advanced heart block, and are not already taking beta-blockers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
This trial tests a full-course strategy using a heart-lung bypass machine (ECMO) for people with moderate-to-severe acute respiratory distress syndrome (ARDS), a serious lung condition. The goal is to see if starting and continuing ECMO throughout treatment improves recovery.
This trial tests a more tailored way to set the amount of air delivered by a ventilator in people with severe ARDS. The goal is to see if personalized breathing settings can improve breathing and heart-related monitoring while patients are in intensive care.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
This trial tests a targeted approach to manage oxygen levels in the brain for patients who received ECMO (a machine that does the heart and lung work) after a cardiac arrest that did not respond to standard CPR. The goal is to improve brain recovery and outcomes.
This trial tests a medication called esmolol (a short-acting beta-blocker) to see if it can improve blood flow in tiny blood vessels (microcirculation) and help stabilize blood pressure in people with septic shock who have a fast heart rate. The goal is to see if slowing the heart rate can improve organ function and recovery.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.